Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline, needing a sales surge, wins FDA nod for $1B-plus prospect Trelegy
GlaxoSmithKline, needing a sales surge, wins FDA nod for $1B-plus prospect Trelegy
GlaxoSmithKline, needing a sales surge, wins FDA nod for $1B-plus prospect Trelegy
Submitted by
admin
on September 19, 2017 - 10:21pm
Source:
Fierce Pharma
News Tags:
GSK
FDA
Trelegy Ellipta
COPD
Headline:
GlaxoSmithKline, needing a sales surge, wins FDA nod for $1B-plus prospect Trelegy
Do Not Allow Advertisers to Use My Personal information